Abbreviations
- ANA:
-
Antinuclear antibodies
- c-ANCA:
-
Cytoplasmic antineutrophil cytoplasmic antibody
- CRP:
-
C-reactive protein
- CS:
-
Corticosteroids
- CT:
-
Computed tomography
- CYC:
-
Cyclophosphamide
- EF:
-
Eosinophilic fasciitis
- EMS:
-
Eosinophilia-myalgia syndrome
- HES:
-
Idiopathic hypereosinophilic syndrome
- HIV:
-
Human immunodeficiency virus
- IgM, IgG, IgA:
-
Immunoglobulin M, G, A
- IL:
-
Interleukin
- IV:
-
Intravenous
- IVIG:
-
Intravenous immunoglobulins
- MAC:
-
Membrane attack complex
- MPO:
-
Myeloperoxidase antibody
- MRA:
-
Magnetic resonance angiography
- MRI:
-
Magnetic resonance imaging
- p-ANCA:
-
Perinuclear antineutrophil cytoplasmic antibody
- PDGFRA:
-
Platelet-derived growth factor receptor alpha
- PR3:
-
Proteinase 3 antibodies
- PUVA:
-
Psoralen plus ultraviolet A
- ROM:
-
Range of motion
- sIgMD:
-
Selective Immunoglobulin M Deficiency
- TGF β:
-
Transforming growth factor-beta
References
Shulman LE (1974) Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol(Suppl 1):82
Shulman LE (1970) Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 88:70–86
Choquet-Kastylevsky G, Kanitakis J, Dumas V, et al. (2001) Eosinophilic fasciitis and simvastatin. Arch Intern Med 161:1456–1457
DeGiovanni C, Chard M, Woollons A (2006) Eosinophilic fasciitis secondary to treatment with atorvastatin. Clin Exp Dermatol 31:131–132
Buchanan RR, Gordon DA, Muckle TJ, et al. (1980) The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy. J Rheumatol 7:733–736
Hashimoto Y, Takahashi H, Matsuo S, et al. (1996) Polymerase chain reaction of Borrelia burgdorferi flagellin gene in Shulman syndrome. Dermatology 192:136–139
Granter SR, Barnhill RL, Duray PH (1996) Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol 18:465–473
Hayashi N, Igarashi A, Matsuyama T, et al. (2000) Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporine. Br J Dermatol 142:830–832
Liou CH, Huang GS, Taylor JA, et al. (2003) Eosinophilic fasciitis in a military recruit: MRI evaluation with clinical correlation. Skeletal Radiol 32:52–57
Littlejohn GO, Keystone EC (1980) Eosinophilic fasciitis and aplastic anemia. J Rheumatol 7:730–732
Khanna D, Verity A, Grossman JM (2002) Eosinophilic fasciitis with multiple myeloma: a new hematological association. Ann Rheum Dis 61:1111–1112
Michaels RM (1982) Eosinophilic fasciitis complicated by Hodgkin’s disease. J Rheumatol 9:473–476
Ohno M, Nagaoka S, Onari K, et al. (2001) Remitting fasciitis without eosinophilia: a new disease entity? A case report. Rheumatology (Oxford) 40:1428–1430
Antic M, Lautenschlager S, Itin PH (2006) Eosinophilic fasciitis 30 years after—What do we really know? Report of 11 patients and review of the literature. Dermatology 213:93–101
Kazatchkine MD, Bayry J, Lacroix-Desmazes S, et al. (2004) Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. In: MC Dalakas, PJ Späth (ed) Intravenous immunoglobulins in the third millennium. The Parthenon Publishing Group, New York, pp 106–107
Agnew KL, Blunt D, Francis ND, et al. (2005) Magnetic resonance imaging in eosinophilic fasciitis. Clin Exp Dermatol 30:435–436
Sugimoto T, Nitta N, Kashiwag A (2007) Usefulness of magnetic resonance imaging in eosinophilic fasciitis. Rheumatol Int 27:791–792
Gotlib J, Cools J, Malone JM III, et al. (2004) The FIP1L1- PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia, implications for diagnosis, classification, and management. Blood 103:2879–2891
Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214
Grobner T (2006) Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108
Galan A, Cowper SE, Bucala R (2006) Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 18:614–617
Pouplin S, Daragon A, Le Loët X, et al. (1998) Treatment of eosinophilic fasciitis with methotrexate. J Rheumatol 25:606–607
Jensen E, Hess B, Hunziker T, et al. (2000) Eosinophilic fasciitis (Shulman syndrome). Schweiz Med Wochenschr 130:156–160
Bukiej A, Dropińsky J, Dyduch G, et al. (2005) Eosinophilic fasciitis successfully treated with cyclosporine, case report. Clin Rheumatol 24:634–636
Valencia IC, Chang A, Kirsner RS, et al. (1999) Eosinophilic fasciitis responsive to treatment with pulse steroids and cyclosporine. Int J Dermatol 38:369–372
Schiener R, Behrens-Williams SC, Gottlöber P, et al. (2000) Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol 142:804–807
Solomon G, Barland P, Rifkin H (1982) Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med 97:547–549
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haiduc, V.F., Erkan, D., Kirou, K. et al. Anti-neutrophil Cytoplasmic Antibody (c-ANCA) Positive Recurrent Eosinophilic Fasciitis Responsive to Cyclophosphamide. HSS Jrnl 4, 81–86 (2008). https://doi.org/10.1007/s11420-007-9067-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-007-9067-y